A Cornell-led collaboration is turning DNA from organic matter – such as onions, fish and algae – into biodegradable gels and plastics. The resulting materials could be used to create plastics and methods for drug delivery.
Researchers from Weill Cornell Medicine and the College of Veterinary Medicine are expanding the potential of precision medicine for canine and human patients, by studying a lymphoma that occurs in both people and dogs.
A statistical analysis of all 50 states and Washington, D.C., found that social distancing measures slowed the spread of coronavirus on the whole, but did not reduce the number of new infections per day.
Collaborating across disparate disciplines to tackle the grand challenges facing humanity is intrinsic to Cornell’s unique brand of research innovation.
When Kaavian Shariati ’20 learned he had Type 1 diabetes shortly before arriving at Cornell, he was shocked not only by his new responsibilities – monitoring his insulin levels day and night – but by the state of diabetes research.
A team including a Cornell researcher has developed a digital “virus” that could piggyback on contact-tracing apps and spread from smartphone to smartphone in real time, helping policymakers predict COVID-19 spread.
